The IPA Foundation (IPA), a non-profit company representing family medical practitioners in private practice, challenged two decisions by the South African Pharmacy Council (SAPC). The SAPC approved the implementation of Pharmacist-Initiated Management of Antiretroviral Therapy (PIMART) services, which would allow specially trained and accredited pharmacists to administer first-line HIV/AIDS treatment. This decision was published in Board Notice 101 of 2021 on 13 August 2021, following Board Notice 71 of 2021 published on 22 March 2021 which invited public comment within 60 days.
The PIMART initiative arose from the Department of Health's request to the SAPC to investigate interventions to increase access to antiretroviral medicines. Despite initiatives like NIMART (Nurse-Initiated Management of Antiretrovirals) since 2010, HIV infection rates remained high, with 8.2 million people affected by 2010. The Department spent over R20 billion on HIV in 2019/2020.
The SAPC published Board Notice 71 in the Government Gazette on 22 March 2021, inviting comments within 60 days. The IPA did not comment within this period, submitting objections only on 8 September 2021, after Board Notice 101 had been published. The IPA then brought a review application in the High Court challenging both the procedural fairness and substantive rationality of the SAPC's decisions.